# Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes

> **NCT06129526** · PHASE4 · UNKNOWN · sponsor: **University of Ioannina** · enrollment: 450 (estimated)

## Conditions studied

- Diabetes Type 2
- Hypertriglyceridemia
- Diabetes Mellitus

## Interventions

- **DIETARY_SUPPLEMENT:** EPAVasc
- **DIETARY_SUPPLEMENT:** Corn Oil

## Key facts

- **NCT ID:** NCT06129526
- **Lead sponsor:** University of Ioannina
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12
- **Primary completion:** 2024-09
- **Final completion:** 2024-12
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2023-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06129526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06129526, "Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06129526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*